OR WAIT null SECS
June 25, 2015
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
June 24, 2015
Juniper Pharma Services has entered into a long-term collaboration with OxSonics to support the development, scale-up, and GMP manufacturing of OxSonics’ proprietary sono-sensitive particles.
The agency clarifies its requirements for allowable excess volume and labeled vial fill size in injectables and biologics.
Reach Separations has announced plans to double its laboratory space at its Nottingham facility as a result of increased demand for its specialist purification services.
June 22, 2015
Monoclonal antibodies can facilitate the entry of radiopharmaceuticals into cells, David Scheinberg said at BIO 2015.
June 19, 2015
The agency takes action against websites that illegally sell unapproved medications.
Biomax Informatics AG and Pierre Fabre announced that they have entered into a collaboration to create an integrated antibody sequence and knowledge database.
June 17, 2015
Experts at Eppendorf discuss common challenges in cell culture and share insights on possible solutions.
June 15, 2015
BPTF seeks changes in performance goals and fee payment schedule in GDUFA renegotiations.
June 09, 2015
The product, marketed as Sirdupla in the United Kingdom, is the generic version of GSK’s beta agonist and corticosteroid combination treatment for asthma.